BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 28595562)

  • 1. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
    Vaseghi G; Rafiee L; Javanmard SH
    Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
    Nafee N; Gouda N
    Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
    Kozielski KL; Rui Y; Green JJ
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
    Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
    Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Delivery Particle Engineering Strategies for Shape-dependent Targeting of Cells and Tissues.
    Kozielski KL; Sitti M
    Curr Gene Ther; 2017; 17(2):80-88. PubMed ID: 28494739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, preparation and application of nucleic acid delivery carriers.
    Yang J; Liu H; Zhang X
    Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
    Vaughan HJ; Green JJ; Tzeng SY
    Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral nucleic acid delivery: key challenges and future directions.
    Elsabahy M; Nazarali A; Foldvari M
    Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle siRNA against BMI-1 with a Polyethylenimine-Laminarin Conjugate for Gene Therapy in Human Breast Cancer.
    Ren X; Liu L; Zhou Y; Zhu Y; Zhang H; Zhang Z; Li H
    Bioconjug Chem; 2016 Jan; 27(1):66-73. PubMed ID: 26629893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges.
    Mirza Z; Karim S
    Semin Cancer Biol; 2021 Feb; 69():226-237. PubMed ID: 31704145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates.
    Gamrad L; Rehbock C; Westendorf AM; Buer J; Barcikowski S; Hansen W
    Sci Rep; 2016 Jul; 6():28709. PubMed ID: 27381215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
    Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
    Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional enveloped nanodevices (MENDs).
    Sato Y; Nakamura T; Yamada Y; Akita H; Harashima H
    Adv Genet; 2014; 88():139-204. PubMed ID: 25409606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and application of glycosylated particulate carriers for delivery of nucleic acid medicine].
    Kawakami S
    Yakugaku Zasshi; 2008 Dec; 128(12):1743-9. PubMed ID: 19043293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-based delivery system for application of siRNA in vivo.
    Wang Y; Li Z; Han Y; Liang LH; Ji A
    Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.